Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

11 Résultats
Structure : Identifiant HAL de la structure : 1074417

Evaluation of the Bio-Evolution Microsporidia generic and typing real-time PCR assays for the diagnosis of intestinal microsporidiosis

Maxime Moniot , Céline Nourrisson , Virginie Bonnin , Céline Damiani , Nicolas Argy , et al.
Parasite, 2022, 29 (55), pp.1-8. ⟨10.1051/parasite/2022055⟩
Article dans une revue hal-03881459v1

Identification of gene expression profiles associated with an Increased risk of post-operative recurrence in Crohn's disease

Marjolaine Ngollo , Kevin Perez , Nassim Hammoudi , Yuri Gorelik , Marc Delord , et al.
Journal of Crohn's and Colitis, 2022, 16 (8), pp.1269--1280. ⟨10.1093/ecco-jcc/jjac021⟩
Article dans une revue hal-03773378v1

Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐ TNF agent

Anthony Buisson , Maria Nachury , Thomas Guilmoteau , Romain Altwegg , Xavier Treton , et al.
Alimentary Pharmacology & Therapeutics (Suppl), 2022, pp.1-13. ⟨10.1111/apt.17305⟩
Article dans une revue hal-03870253v1

Epidemiological and clinical study of microsporidiosis in French kidney transplant recipients from 2005 to 2019: TRANS‐SPORE registry

Clément Dumond , Florence Aulagnon , Isabelle Etienne , Anne‐elisabeth Heng , Marie‐elisabeth Bougnoux , et al.
Transplant Infectious Disease, 2021, 23 (5), ⟨10.1111/tid.13708⟩
Article dans une revue hal-03419373v1

Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study

Lucas Guillo , Benoit Flachaire , Jérôme Avouac , Catherine Dong , Maria Nachury , et al.
Digestive and Liver Disease, 2023, 55 (1), pp.61-68. ⟨10.1016/j.dld.2022.07.012⟩
Article dans une revue hal-04167918v1
Image document

Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study

Laurent Peyrin-Biroulet , Guillaume Bouguen , David Laharie , Gauthier Pellet , Guillaume Savoye , et al.
Digestive Diseases and Sciences, 2022, 67 (12), pp.5637-5646. ⟨10.1007/s10620-022-07474-z⟩
Article dans une revue hal-03657045v1

Checking the absence of inflammatory activity with an objective marker, a key point to succeed the switch from intravenous to subcutaneous infliximab in inflammatory bowel disease

Anthony Buisson , Maria Nachury , Mathurin Fumery
Clinical Gastroenterology and Hepatology, 2022, ⟨10.1016/j.cgh.2022.11.006⟩
Article dans une revue hal-03870157v1

Comparison of the risk of Crohn's disease postoperative recurrence between modified Rutgeerts score i2a and i2b categories: an individual patient data meta-analysis

Pauline Rivière , Joel Pekow , Nassim Hammoudi , Pauline Wils , Peter de Cruz , et al.
Journal of Crohn's and Colitis, 2022, pp.jjac137. ⟨10.1093/ecco-jcc/jjac137⟩
Article dans une revue hal-03783917v1

Role of adherent and invasive Escherichia coli in Crohn’s disease: lessons from the postoperative recurrence model

Anthony Buisson , Harry Sokol , Nassim Hammoudi , Stéphane Nancey , Xavier Treton , et al.
Article dans une revue hal-03745296v1
Image document

Evolution of endoscopic lesions in steroid-refractory acute severe ulcerative colitis responding to infliximab or cyclosporine

David Laharie , Arnaud Bourreille , Julien Branche , Matthieu Allez , Yoram Bouhnik , et al.
Clinical Gastroenterology and Hepatology, 2021, 19 (6), pp.1180-1188.e4. ⟨10.1016/j.cgh.2020.08.001⟩
Article dans une revue hal-03551241v1

Comparative acceptability of therapeutic maintenance regimens in patients with inflammatory bowel disease: results from the nationwide ACCEPT2 Study.

Anthony Buisson , Mélanie Serrero , Laurie Orsat , Stéphane Nancey , Pauline Rivière , et al.
Inflammatory Bowel Diseases, 2022, ⟨10.1093/ibd/izac119⟩
Article dans une revue hal-03723436v1